These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2066706)
1. Pathogenetic mechanism of stroke in non-valvular atrial fibrillation: follow-up of stroke patients with and without atrial fibrillation. Gustafsson C; Britton M J Intern Med; 1991 Jul; 230(1):11-6. PubMed ID: 2066706 [TBL] [Abstract][Full Text] [Related]
2. Recurrence of embolic stroke in non-valvular atrial fibrillation (NVAF). An autopsy study. Yamanouchi H; Shimada H; Tomonaga M; Matsushita S Acta Neurol Scand; 1989 Aug; 80(2):123-9. PubMed ID: 2816274 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. Olesen JB; Fauchier L; Lane DA; Taillandier S; Lip GYH Chest; 2012 Jan; 141(1):147-153. PubMed ID: 21680645 [TBL] [Abstract][Full Text] [Related]
4. Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation. Yasaka M; Yamaguchi T CNS Drugs; 2001; 15(8):623-31. PubMed ID: 11524034 [TBL] [Abstract][Full Text] [Related]
5. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project. Banerjee A; Taillandier S; Olesen JB; Lane DA; Lallemand B; Lip GY; Fauchier L Int J Cardiol; 2013 Sep; 167(6):2682-7. PubMed ID: 22795403 [TBL] [Abstract][Full Text] [Related]
6. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet; 1994 Mar; 343(8899):687-91. PubMed ID: 7907677 [TBL] [Abstract][Full Text] [Related]
7. Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease. Sage JI; Van Uitert RL Stroke; 1983; 14(4):537-40. PubMed ID: 6658928 [TBL] [Abstract][Full Text] [Related]
8. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet; 1993 Nov; 342(8882):1255-62. PubMed ID: 7901582 [TBL] [Abstract][Full Text] [Related]
9. Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study. Jung H; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B Thromb Haemost; 2019 Feb; 119(2):285-293. PubMed ID: 30602200 [TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project). Sandercock P; Bamford J; Dennis M; Burn J; Slattery J; Jones L; Boonyakarnkul S; Warlow C BMJ; 1992 Dec; 305(6867):1460-5. PubMed ID: 1493391 [TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation in older stroke patients: association with recurrence and mortality after first ischemic stroke. Kaarisalo MM; Immonen-Räihä P; Marttila RJ; Lehtonen A; Salomaa V; Sarti C; Sivenius J; Torppa J; Tuomilehto J J Am Geriatr Soc; 1997 Nov; 45(11):1297-301. PubMed ID: 9361653 [TBL] [Abstract][Full Text] [Related]
12. Ten year cerebrovascular morbidity and mortality in 68 year old men with asymptomatic carotid stenosis. Ogren M; Hedblad B; Isacsson SO; Janzon L; Jungquist G; Lindell SE BMJ; 1995 May; 310(6990):1294-8. PubMed ID: 7773042 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. Gage BF; Cardinalli AB; Albers GW; Owens DK JAMA; 1995 Dec; 274(23):1839-45. PubMed ID: 7500532 [TBL] [Abstract][Full Text] [Related]
14. Thromboembolic events in paroxysmal vs. permanent non-valvular atrial fibrillation. Subanalysis of the J-RHYTHM Registry. Inoue H; Atarashi H; Okumura K; Yamashita T; Kumagai N; Origasa H Circ J; 2014; 78(10):2388-93. PubMed ID: 25099606 [TBL] [Abstract][Full Text] [Related]
15. Mortality in acute stroke with atrial fibrillation. The Italian Acute Stroke Study Group. Candelise L; Pinardi G; Morabito A Stroke; 1991 Feb; 22(2):169-74. PubMed ID: 2003280 [TBL] [Abstract][Full Text] [Related]
16. Primary and secondary prevention of stroke and systemic embolism with rivaroxaban in patients with non-valvular atrial fibrillation : Sub-analysis of the EXPAND Study. Uchiyama S; Atarashi H; Inoue H; Kitazono T; Yamashita T; Shimizu W; Ikeda T; Kamouchi M; Kaikita K; Fukuda K; Origasa H; Shimokawa H Heart Vessels; 2019 Jan; 34(1):141-150. PubMed ID: 29980835 [TBL] [Abstract][Full Text] [Related]
17. Heparin in acute stroke with atrial fibrillation: clinical relevance of very early treatment. Chamorro A; Vila N; Ascaso C; Blanc R Arch Neurol; 1999 Sep; 56(9):1098-102. PubMed ID: 10488810 [TBL] [Abstract][Full Text] [Related]
18. Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study. Xiang W; Zhang J; Liu M; Liu F; Feng X; Wang Y Clin Interv Aging; 2015; 10():515-9. PubMed ID: 25767378 [TBL] [Abstract][Full Text] [Related]
19. Diabetic atrial fibrillation patients: mortality and risk for stroke or embolism during a 10-year follow-up. Klem I; Wehinger C; Schneider B; Hartl E; Finsterer J; Stöllberger C Diabetes Metab Res Rev; 2003; 19(4):320-8. PubMed ID: 12879410 [TBL] [Abstract][Full Text] [Related]